Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Irani

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]T Seisen, E Compérat, P Colin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 25, 2010
[What's new in 2009 about urothelial tumors? Live from EAU, AUA and ASCO, ASCO-GU]D Amsellem-Ouazana, C Theodore, J Irani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2018
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive diseaseA Kamoun, G Cancel-Tassin, G Fromont, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]L Salomon, S Bastuji-Garin, M Soulie, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]I Durand-Zaleski, H Rabetrano, M Devonec, et al.
Actas Urologicas Espanolas|June 20, 2021
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patientsF Pisano, P Gontero, R Sylvester, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]L Salomon, S Bastuji-Garin, C Mazerolles, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
World Journal of Urology|September 2, 2018
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomyFrancesco Soria, Francesca Pisano, Paolo Gontero, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]T Seisen, E Compérat, P Colin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 25, 2010
[What's new in 2009 about urothelial tumors? Live from EAU, AUA and ASCO, ASCO-GU]D Amsellem-Ouazana, C Theodore, J Irani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2018
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive diseaseA Kamoun, G Cancel-Tassin, G Fromont, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]L Salomon, S Bastuji-Garin, M Soulie, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]I Durand-Zaleski, H Rabetrano, M Devonec, et al.
Actas Urologicas Espanolas|June 20, 2021
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patientsF Pisano, P Gontero, R Sylvester, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]L Salomon, S Bastuji-Garin, C Mazerolles, et al.
World Journal of Urology|May 4, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thoughtJ Palou, F Pisano, R Sylvester, et al.
World Journal of Urology|September 2, 2018
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomyFrancesco Soria, Francesca Pisano, Paolo Gontero, et al.
Pageof 17